Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling
Science Advances · 2025
DOI: 10.1126/sciadv.adr7208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Ping Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin 1500086, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Signal Transduction, Silicates, Inflammation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Inflammatory dilated cardiomyopathy (iDCM) represents a severe immune-related condition provoked by the progression of myocarditis. In patients suffering from myocarditis, a vicious cycle of inflammation orchestrated by CD4 + T cells, neutrophils, and fibroblasts is the culprit that drives the deterioration of myocarditis into iDCM. This study designed composite microneedles and ion solutions using calcium silicate bioceramics, which deliver SiO 3 2− directly into myocardial tissue or indirectly via systemic circulation. These interventions modulate the cell microenvironment by regulating CD4 + T/T helper 17 (T H 17) cells and their interactions with neutrophils and fibroblasts through the forkhead box O (FOXO) signaling pathway. Specifically, SiO 3 2− inhibits the hyperdifferentiation of CD4 + T cells to T H 17 cells by regulating FOXO1 and neutrophils to neutrophil extracellular traps as well as fibroblasts to myofibroblasts by regulating FOXO3, thereby ultimately disrupting the vicious cycle of myocardial inflammation and subsequent fibrotic lesions in iDCM. This discovery indicates that the biomaterial-based strategy may have great potential for the treatment of iDCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin 1500086, China.
- The Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin 150086, China.
- Ultrasound Molecular Imaging Joint Laboratory of Heilongjiang Province, Harbin 150086, China.
- Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
- Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325000, China.
- State Key Laboratory of High-Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, People's Republic of China.
ORCID-Profile: Ping Sun, Zhaowenbin Zhang, Fei Gao, Chen Yang, Ge Mang, Shuai Fu, Jiawei Tian, Jiang Chang
Zitieren
APA
Sun, P., Zhang, Z., Gao, F., Yang, C., Mang, G., Fu, S., Tian, J., & Chang, J. (2025). Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling. Science Advances. https://doi.org/10.1126/sciadv.adr7208
Vancouver
Sun P, Zhang Z, Gao F, Yang C, Mang G, Fu S, et al. Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling. Science Advances. 2025. doi:10.1126/sciadv.adr7208
BibTeX
@article{Sun2025,
author = {Sun, Ping and Zhang, Zhaowenbin and Gao, Fei and Yang, Chen and Mang, Ge and Fu, Shuai and Tian, Jiawei and Chang, Jiang},
title = {Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adr7208}
}
EUVIMED